| 1 | Based on oral and dermal pathways. CLEA Briefing note 1 states that although SGV reports have been published for both arsenic and cadmium. It should be noted that in both cases exposure via the dermal route was excluded on the basis of the discussion of toxicological effects in the relevant TOX reports. It is considered prudent to examine the implications for exposure of the consultation guidance issued by the USEPA (2001) which recommended dermal absorption fractions for both arsenic and cadmium. |
